• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Covance Opens Offices in Seoul, Mumbai

Covance Opens Offices in Seoul, Mumbai

December 17, 2009
CenterWatch Staff

Covance recently opened new clinical development offices in Seoul, South Korea, and Mumbai, India, building on the contract research organization’s (CRO) two-decade history in the Asia-Pacific region.

The new and expanded offices will help the CRO meet growing demand for clinical development services in Asia-Pacific. The Seoul office will increase patient access in the region and support Covance’s field-based clinical research associates throughout Asia-Pacific, while the Mumbai office will serve as the CRO’s main support hub for the Indian sub-continent.

The company also expanded its offices in Tokyo, Japan, and Hong Kong, China, to increase service capacity in these countries. The Tokyo office will provide additional room for both clinical development and central laboratory services in the Japanese clinical trial market.

"Our new Asia-Pacific offices support our global expansion strategy, which targets the most qualified investigators and appropriate patient populations in a region that is increasingly important to clinical trials," said Nick Wright, vice president and general manager, clinical development services Asia-Pacific, Covance. "These offices will help us increase our clients' phase II/III clinical trial productivity by providing additional capacity to execute clinical studies with a full range of services."

The year 2009 was a big year for growth in emerging markets at Covance, which opened nine new offices in Asia Pacific, Latin America and Eastern Europe.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing